Claim OwnershipBTOG - British Thoracic Oncology Group
Subscribed: 22Played: 573
Subscribe
© btog
Description
The British Thoracic Oncology Group (BTOG) is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK.
BTOG's mission is to support and educate thoracic oncology healthcare professionals, creating a professional community to exchange ideas, information and innovation and to foster the development of research. The overall aim is to represent the needs of people with thoracic malignancies in the UK and ensure they have equitable access to optimal care.
Find out more here - https://www.btog.org/
70 Episodes
Reverse
Join BTOG and the UKLCC to discuss the recent UKLCC conference “UK Lung Cancer: 20 years on – what’s next?”
Participants:
Dr Tom Newsom-Davis, Chair, BTOG Steering Committee and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London
Dr Emma O’Dowd, BTOG Steering Committee Member and Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University
Dr David Gilligan, UKLCC Chair and Consultant Clinical Oncologist at Cambridge University Hospitals & Royal Papworth Hospitals, Cambridge, UK and an Affiliated Assistant Professor at the University of Cambridge.
A look at the top 10 abstracts – the rationale and design, efficacy, side effects and potential impact with Dr Tom Newsom-Davis, Chair, BTOG and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London; Dr Shobhit Baijal, BTOG Steering Committee Member and Consultant Medical Oncologist, University Hospital Birmingham NHS Trust, Birmingham and; Dr Sharmistha Ghosh, Associate Specialist Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London.
In this episode of the series, BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.
In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Jason Adhikaree, Clinical Associate Professor in Oncology/Honorary Consultant in Medical Oncology, at Nottingham NHS Trust.
In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Miss Sofina Begum, Consultant Thoracic Surgeon at Royal Brompton Hospital.
BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Dr Helen Liddicoat, Respiratory Physician from Dundee. Helen is Bronchoscopy Lead at her hospital and sits on the National Faculty for Advanced Bronchoscopy and Endobronchial Ultrasound at NHS Education Scotland.
Key highlights from the 2025 ASCO Annual Meeting, held in Chicago. Our expert panel review the most practice-changing presentations in thoracic oncology and discuss their potential impact on clinical care in the UK.
Topics include major advances in immunotherapy, precision medicine, radiotherapy trials, small cell lung cancer trials, liquid biopsy and supportive care — with a focus on what UK clinicians need to know. This is an excellent opportunity to catch up on key data and emerging trends from the world’s largest cancer conference.
BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Professor Sanjay Agrawal, Consultant in Respiratory & Intensive Care Medicine, University Hospitals of Leicester NHS Trust. Sanjay is also National Speciality Advisor for Tobacco Dependency at NHS England and Speciality Advisor on Tobacco at the Royal College of Physicians.
The National Lung Cancer Audit (NLCA), commissioned by the Healthcare Quality Improvement Partnership (HQIP), evaluates the care received by patients diagnosed with lung cancer in NHS hospitals within England and Wales. We aim to stimulate quality improvement activities and reduce variation in the care, treatment and outcomes of patients diagnosed with lung cancer.
Dr Tom Newsom-Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital and Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham were joined by Dr Riyaz Shah, Consultant Medical Oncologist at the Kent Oncology Centre to talk about the HER2 Mutation.
BTOG does … MET Podcast is now released – this is part 5 of a series looking at mutations in lung cancer – we have already looked at BRAF, KRAS, RET and ROS1.
Recorded recently, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect discussed MET with Dr Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology at University of Newcastle upon Tyne.
Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of both WCLC 2024 and ESMO 2024.
WCLC 2024 Highlights - Martin Forster, Consultant Medical Oncologist and Associate Professor, University College Hospital
ESMO 2024 Metastatic Disease Highlights - Meenali Chitnis, Consultant Medical Oncologist, Oxford Cancer & Haematology Centre
ESMO 2024 Early and Locally Advanced Disease Highlights - Yvonne Summers, Consultant in Medical Oncology, The Christie NHS Foundation Trust
Panel Discussion led by Chair
Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of ASCO 2024 held May 31 - June 4 in Chicago.
Broadcast live on Monday 17 June 2024 18.00-19.15
Targeted Therapies in Advanced Stage NSCLC Dr Louise Lim, Consultant Medical Oncologist, St Bartholomew's Hospital
Immunotherapy in Advanced Stage NSCLC Dr Tom Newsom-Davis, Consultant in Medical Oncology, Chelsea and Westminster Hospital
Locally Advanced NSCLC, Small Cell Carcinoma and Mesothelioma Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Panel Discussion led by Chair
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Chair Elect is joined for this podcast by clinical oncology colleagues, Professor Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology, University of Manchester and Honorary Consultant Clinical Oncologist, The Christie NHS Foundation Trust and Dr Fiona McDonald, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust.
Chaired by Neal Navani, NLCA Senior Clinical Lead and BTOG Steering Committee Member, this webinar presented the NLCA State of the Nation Report 2024.
Following on from Professor Eric Lim’s presentation “MARS2: results and UK implications” at BTOG 2024, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect, discusses Mesothelioma and Surgery with Professor Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital and Professor of Thoracic Surgery, Imperial College London and Mr David Waller, Consultant Thoracic Surgeon at Barts Health NHS Trust.
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Professor Najib M Rahman, Professor of Respiratory Medicine, Director, Oxford Respiratory Trials Unit and Nuffield Department of Medicine, University of Oxford
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Meenali Chitnis, Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust.
BTOG does ... RET – this is part 3 of a series looking at mutations in lung cancer – we have already looked at BRAF and KRAS. Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Nadza Tokaca, Consultant Medical Oncologist at the Royal Marsden Hospital.
Chaired by Professor Sanjay Popat, this webinar covered clinically impactful thoracic oncology highlights of ESMO 2023 held in Madrid.
The speakers are:
Dr Tom Newsom-Davis
Consultant in Medical Oncology, Chelsea and Westminster Hospital, London
Dr Riyaz Shah
Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Dr Yvonne Summers
Consultant in Medical Oncology, The Christie NHS Foundation Trust
Originally live on Wednesday 8th November 2023, 18:00-19:10
Comments
Download from Google Play
Download from App Store
United States